Business Context and Reporting Period
This Form 8-K Current Report was filed by GoodRx Holdings, Inc. on July 8, 2024. The filing primarily addresses corporate governance changes, specifically the election of a new director and the restructuring of Board committees.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to director compensation:
- Initial RSU Award: $420,000 value.
- Pro-rated Annual RSU Award: $209,836 value.
- Annual Cash Retainer: $30,000 (prorated).
- Committee Retainers: $15,000 for Chair of Innovation Committee and $10,000 for Nominating and Corporate Governance Committee member (both prorated).
- Future Annual RSU Target: $230,000.
Material Changes
The following material changes to the Board of Directors and committee structure were effective July 8, 2024:
- Director Election: Ian T. Clark was elected as a Class III director to fill the vacancy left by Stephen LeSieur, who resigned on March 14, 2024. Mr. Clark's term expires at the 2026 Annual Meeting.
- Committee Restructuring: The Audit Committee and Compliance Committee were combined into a single "Audit and Risk Committee."
- New Committee: A new "Innovation Committee" was established.
- Committee Assignments: Ian T. Clark was appointed Chair of the Innovation Committee and a member of the Nominating and Corporate Governance Committee.
Guidance, Outlook, and Risks
This filing contains no financial guidance, outlook, or management commentary regarding business operations. No specific risks or contingencies were disclosed in this report, other than standard references to the terms of the director compensation program and the Deferred Compensation Plan.
Investor Verification Checklist
- Verify the independence status of Ian T. Clark under Nasdaq rules as stated by the Board.
- Review the vesting schedules for the $420,000 initial RSU award and the $209,836 pro-rated award.
- Confirm the updated composition of the Audit and Risk Committee and the new Innovation Committee.
- Check for any related party transactions involving Mr. Clark, though the filing states none exist subject to disclosure.